Article
Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Cancer research - 1 May 1998
Gallagher A P, Burnett A K, Bowen D T, Darley R L
Abstract excerpt
RAS mutations arise at high frequency in human malignancy and have been shown to play a role in the disruption of both normal differentiation and proliferation. In addition, RAS influences a number of intracellular signaling pathways, which impinge on proteins that regulate programmed cell death. In this study, we have examined whether this oncogene can influence the activation of the apoptotic process induced by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
